TMO
サーモ・フィッシャー・サイエンティフィック
TMO
サーモ・フィッシャー・サイエンティフィック
Thermo Fisher Scientific NYSE: TMO Chairman and Chief Executive Officer Marc Casper said the company is seeing improving demand across several end markets and expects 2026 to be an “outstanding year,”
Pharmaceuticals are rebounding as U.S. drug pricing clarity emerges, shifting focus to patent expirations and innovation-driven differentiation. Companies like JNJ and AZN, with diversified portfolios
Diageo PLC (LSE:DGE) has appointed former Procter & Gamble Beauty chief executive R. Alexandra “Alex” Keith as a non-executive director, adding more than 35 years of international consumer goods exper
Thermo Fisher Scientific is rated a Buy, supported by accelerating organic growth and improving Pharma and Biotech end markets. TMO's recent acquisitions of Clario and Solventum's Filtration and Separ
Thermo Fisher Scientific NYSE: TMO reported stronger-than-expected second-quarter 2026 results and raised its full-year outlook, citing improving customer activity across end markets, broad-based grow
In a year already marked by headlines of Ebola outbreaks and flashback-inducing cruise ship quarantines, everyday foodborne threats are delivering a sharp reminder of supply chain vulnerability. Since